Skip to content
TirzepatideReport

Tracked provider

NexLife tirzepatide review

NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

This is a tracked entry: the facts below are what NexLife publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-20). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on NexLife's own site before you pay.

What it costs

Tirzepatide
$215/mo (compounded)
What is dispensed
Compounded tirzepatide
Who compounds it
Unspecified

How the program works

A live video visit is required before a prescription. Publishes its price before you start the intake.

What we like

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

The caveats

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

Ready to look at NexLife directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit NexLife

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review